Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

ASTRAZENECA AB🇨🇳 National Medical Products Administration

Approval Id: 8TEMKuRTPHl
Approval Number: 国药准字HJ20230077
Generic Name: 达格列净二甲双胍缓释片(Ⅰ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 达格列净5mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍500mg
Reg Date: 2023-12-18
Expired Date: 2028-06-20
Company Name: ASTRAZENECA AB
Production Company Name: ASTRAZENECA PHARMACEUTICALS LP
Company Detail Path: /organization/astrazeneca-ab
Production Company Detail Path: /organization/astrazeneca-pharmaceuticals-lp

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 18, 2023

Approval ID

8TEMKuRTPHl

Type

化学药品